Biotricity Accumulated Retained Earnings Deficit vs Trade and Non Trade Receivables Analysis

BTCY Stock

USD 1.27 0.07 5.83%

Trend analysis of Biotricity balance sheet accounts such as Short Long Term Debt Total of 23.6 M, Other Current Liabilities of 977.3 K or Total Current Liabilities of 13.5 M provides information on Biotricity's total assets, liabilities, and equity, which is the actual value of Biotricity to its prevalent stockholders. By breaking down trends over time using Biotricity balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Total Assets Total Current Assets

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.

About Biotricity Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Biotricity at a specified time, usually calculated after every quarter, six months, or one year. Biotricity Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Biotricity and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Biotricity currently owns. An asset can also be divided into two categories, current and non-current.

Biotricity Balance Sheet Chart

Biotricity Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Biotricity uses and utilizes its capital. It also shows what exactly a company owns and owes.

At this time, Biotricity's Total Liabilities is fairly stable compared to the past year. Short Term Debt is likely to rise to about 6.2 M in 2024, whereas Other Current Liabilities is likely to drop slightly above 977.3 K in 2024.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Biotricity assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Biotricity books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Biotricity balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Biotricity are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most indicators from Biotricity's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biotricity current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.At this time, Biotricity's Selling General Administrative is fairly stable compared to the past year. Enterprise Value is likely to rise to about 11.4 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 2.2 M in 2024.

Biotricity fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Tangible Assets	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Short Term Investments	Inventory
Total Assets		0.78	0.2	0.6	-0.49	0.61	0.53	-0.81	0.57	0.82	0.82	0.89	0.58	0.28	0.8	0.79	0.76	0.97	0.57	0.7	-0.3	0.76	0.83	0.75	0.66	0.62
Short Long Term Debt Total	0.78		0.24	0.88	-0.9	0.72	0.94	-0.93	0.95	0.3	0.3	0.9	0.6	0.34	0.99	0.92	0.99	0.62	0.88	0.74	-0.26	0.99	0.87	0.78	0.75	0.97
Other Current Liab	0.2	0.24		0.63	-0.4	0.38	0.23	-0.4	0.31	0.06	0.06	0.44	0.53	0.1	0.17	0.38	0.35	0.2	0.56	0.46	-0.92	0.14	0.25	0.2	0.3	0.2
Total Current Liabilities	0.6	0.88	0.63		-0.93	0.77	0.88	-0.9	0.92	0.1	0.1	0.87	0.7	0.31	0.82	0.88	0.93	0.44	0.99	0.77	-0.62	0.83	0.74	0.69	0.77	0.87
Total Stockholder Equity	-0.49	-0.9	-0.4	-0.93		-0.67	-0.97	0.85	-0.97	0.07	0.07	-0.75	-0.58	-0.3	-0.86	-0.82	-0.93	-0.31	-0.94	-0.69	0.38	-0.89	-0.75	-0.68	-0.69	-0.95
Current Deferred Revenue	0.61	0.72	0.38	0.77	-0.67		0.65	-0.88	0.76	0.26	0.26	0.77	0.9	0.33	0.68	0.91	0.75	0.5	0.81	0.89	-0.49	0.69	0.62	0.7	0.81	0.67
Net Debt	0.53	0.94	0.23	0.88	-0.97	0.65		-0.83	0.98	-0.04	-0.04	0.75	0.49	0.3	0.92	0.82	0.95	0.33	0.9	0.63	-0.21	0.94	0.75	0.66	0.69	0.99
Retained Earnings	-0.81	-0.93	-0.4	-0.9	0.85	-0.88	-0.83		-0.89	-0.4	-0.4	-0.94	-0.82	-0.37	-0.9	-0.97	-0.94	-0.7	-0.9	-0.91	0.48	-0.9	-0.87	-0.86	-0.84	-0.86
Accounts Payable	0.57	0.95	0.31	0.92	-0.97	0.76	0.98	-0.89		0.02	0.02	0.79	0.63	0.32	0.92	0.89	0.96	0.38	0.94	0.74	-0.32	0.94	0.75	0.72	0.74	0.98
Cash	0.82	0.3	0.06	0.1	0.07	0.26	-0.04	-0.4	0.02		1.0	0.53	0.33	0.12	0.35	0.38	0.26	0.92	0.05	0.39	-0.18	0.27	0.48	0.43	0.29	0.07
Cash And Short Term Investments	0.82	0.3	0.06	0.1	0.07	0.26	-0.04	-0.4	0.02	1.0		0.53	0.33	0.12	0.35	0.38	0.26	0.92	0.05	0.39	-0.18	0.27	0.48	0.43	0.29	0.07
Net Receivables	0.89	0.9	0.44	0.87	-0.75	0.77	0.75	-0.94	0.79	0.53	0.53		0.7	0.33	0.86	0.9	0.91	0.8	0.85	0.8	-0.51	0.86	0.86	0.8	0.85	0.8
Common Stock Total Equity	0.58	0.6	0.53	0.7	-0.58	0.9	0.49	-0.82	0.63	0.33	0.33	0.7		0.49	0.58	0.82	0.64	0.55	0.71	0.97	-0.63	0.56	0.64	0.72	0.7	0.52
Common Stock Shares Outstanding	0.28	0.34	0.1	0.31	-0.3	0.33	0.3	-0.37	0.32	0.12	0.12	0.33	0.49		0.33	0.35	0.34	0.24	0.32	0.49	-0.09	0.33	0.35	0.33	0.3	0.32
Non Current Liabilities Total	0.8	0.99	0.17	0.82	-0.86	0.68	0.92	-0.9	0.92	0.35	0.35	0.86	0.58	0.33		0.9	0.97	0.65	0.82	0.73	-0.2	0.99	0.87	0.76	0.71	0.95
Other Stockholder Equity	0.79	0.92	0.38	0.88	-0.82	0.91	0.82	-0.97	0.89	0.38	0.38	0.9	0.82	0.35	0.9		0.93	0.66	0.89	0.9	-0.44	0.89	0.81	0.79	0.77	0.86
Total Liab	0.76	0.99	0.35	0.93	-0.93	0.75	0.95	-0.94	0.96	0.26	0.26	0.91	0.64	0.34	0.97	0.93		0.6	0.93	0.77	-0.37	0.97	0.86	0.78	0.78	0.97
Total Current Assets	0.97	0.62	0.2	0.44	-0.31	0.5	0.33	-0.7	0.38	0.92	0.92	0.8	0.55	0.24	0.65	0.66	0.6		0.41	0.66	-0.3	0.59	0.78	0.7	0.55	0.43
Short Term Debt	0.57	0.88	0.56	0.99	-0.94	0.81	0.9	-0.9	0.94	0.05	0.05	0.85	0.71	0.32	0.82	0.89	0.93	0.41		0.77	-0.57	0.85	0.72	0.72	0.78	0.89
Common Stock	0.7	0.74	0.46	0.77	-0.69	0.89	0.63	-0.91	0.74	0.39	0.39	0.8	0.97	0.49	0.73	0.9	0.77	0.66	0.77		-0.55	0.71	0.8	0.83	0.74	0.66
Net Tangible Assets	-0.3	-0.26	-0.92	-0.62	0.38	-0.49	-0.21	0.48	-0.32	-0.18	-0.18	-0.51	-0.63	-0.09	-0.2	-0.44	-0.37	-0.3	-0.57	-0.55		-0.18	-0.27	-0.36	-0.47	-0.19
Non Current Assets Total	0.76	0.99	0.14	0.83	-0.89	0.69	0.94	-0.9	0.94	0.27	0.27	0.86	0.56	0.33	0.99	0.89	0.97	0.59	0.85	0.71	-0.18		0.86	0.79	0.73	0.97
Non Currrent Assets Other	0.83	0.87	0.25	0.74	-0.75	0.62	0.75	-0.87	0.75	0.48	0.48	0.86	0.64	0.35	0.87	0.81	0.86	0.78	0.72	0.8	-0.27	0.86		0.86	0.66	0.8
Other Assets	0.75	0.78	0.2	0.69	-0.68	0.7	0.66	-0.86	0.72	0.43	0.43	0.8	0.72	0.33	0.76	0.79	0.78	0.7	0.72	0.83	-0.36	0.79	0.86		0.76	0.7
Short Term Investments	0.66	0.75	0.3	0.77	-0.69	0.81	0.69	-0.84	0.74	0.29	0.29	0.85	0.7	0.3	0.71	0.77	0.78	0.55	0.78	0.74	-0.47	0.73	0.66	0.76		0.7
Inventory	0.62	0.97	0.2	0.87	-0.95	0.67	0.99	-0.86	0.98	0.07	0.07	0.8	0.52	0.32	0.95	0.86	0.97	0.43	0.89	0.66	-0.19	0.97	0.8	0.7	0.7

Click cells to compare fundamentals

Biotricity Account Relationship Matchups

Biotricity fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.0M	4.4M	16.7M	6.5M	7.5M	7.9M
Short Long Term Debt Total	2.3M	4.7M	15.4M	19.5M	22.5M	23.6M
Other Current Liab	427.6K	3.6M	520.7K	1.0M	1.2M	977.3K
Total Current Liabilities	3.8M	10.5M	4.9M	11.2M	12.8M	13.5M
Total Stockholder Equity	(3.0M)	(6.8M)	(2.1M)	(19.8M)	(17.9M)	(17.0M)
Net Debt	1.4M	2.5M	3.3M	19.0M	21.8M	22.9M
Retained Earnings	(46.4M)	(62.8M)	(93.0M)	(112.6M)	(101.3M)	(96.2M)
Accounts Payable	1.1M	1.0M	1.2M	3.4M	4.0M	4.1M
Cash	949.8K	2.2M	12.1M	570.5K	656.0K	623.2K
Cash And Short Term Investments	949.8K	2.2M	12.1M	570.5K	656.0K	623.2K
Net Receivables	623.3K	1.8M	2.4M	1.8M	2.1M	2.2M
Common Stock Total Equity	31.9K	35.4K	36.4K	39.0K	44.9K	27.8K
Common Stock Shares Outstanding	6.0M	6.3M	7.6M	8.7M	10.0M	7.3M
Liabilities And Stockholders Equity	2.0M	4.4M	16.7M	6.5M	7.5M	7.9M
Non Current Liabilities Total	1.2M	780.9K	14.0M	15.2M	17.5M	18.3M
Other Stockholder Equity	44.2M	56.6M	91.6M	92.8M	106.7M	112.1M
Total Liab	5.0M	11.3M	18.8M	26.4M	30.3M	31.8M
Total Current Assets	1.7M	4.3M	15.3M	4.7M	5.4M	3.2M
Accumulated Other Comprehensive Income	(857.3K)	(634.2K)	(768.7K)	(152.8K)	(137.5K)	(144.4K)
Short Term Debt	2.3M	4.3M	1.8M	5.1M	5.9M	6.2M
Common Stock	36.4K	39.0K	51.3K	52.5K	60.4K	33.8K
Net Tangible Assets	(1.8M)	(3.0M)	(6.8M)	(2.1M)	(1.9M)	(2.0M)
Non Current Assets Total	345.6K	116.5K	1.4M	1.8M	2.1M	2.2M
Inventory	85.7K	272.5K	842.9K	2.3M	2.7M	2.8M
Other Current Assets	137.1K	326.7K	406.3K	588.6K	676.9K	710.7K
Short Long Term Debt	2.1M	4.3M	1.5M	4.8M	5.5M	5.8M
Net Invested Capital	(932.1K)	(2.2M)	11.9M	(2.0M)	(2.3M)	(2.2M)
Net Working Capital	(2.1M)	(6.2M)	10.5M	(6.4M)	(5.8M)	(5.5M)
Capital Stock	36.4K	39.0K	51.3K	52.5K	60.4K	47.2K

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biotricity in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biotricity's short interest history, or implied volatility extrapolated from Biotricity options trading.

Pair Trading with Biotricity

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biotricity position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotricity will appreciate offsetting losses from the drop in the long position's value.

Moving together with Biotricity Stock

0.81	ELMD	Electromed	Pair Corr
0.63	FEMY	Femasys Financial Report 9th of May 2024	Pair Corr

Moving against Biotricity Stock

0.77	IVP	Inspire Veterinary	Pair Corr
0.71	TFX	Teleflex Incorporated Financial Report 2nd of May 2024	Pair Corr
0.68	EMBC	Embecta Corp Financial Report 10th of May 2024	Pair Corr
0.59	DYNT	Dynatronics Financial Report 9th of May 2024	Pair Corr
0.57	AHG	Akso Health Group	Pair Corr

The ability to find closely correlated positions to Biotricity could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biotricity when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biotricity - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biotricity to buy it.

The correlation of Biotricity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biotricity moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biotricity moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Biotricity can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Biotricity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biotricity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biotricity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biotricity Stock:

How To Invest In Biotricity

Details

Is Biotricity Stock a good investment?

Details

What is Biotricity's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.

Note that the Biotricity information on this page should be used as a complementary analysis to other Biotricity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Complementary Tools for Biotricity Stock analysis

When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.

	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Content Syndication Quickly integrate customizable finance content to your own investment portal

Is Biotricity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biotricity. If investors know Biotricity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biotricity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.75)

Revenue Per Share

1.319

Quarterly Revenue Growth

0.209

Return On Assets

(0.95)

Return On Equity

(41.01)

The market value of Biotricity is measured differently than its book value, which is the value of Biotricity that is recorded on the company's balance sheet. Investors also form their own opinion of Biotricity's value that differs from its market value or its book value, called intrinsic value, which is Biotricity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biotricity's market value can be influenced by many factors that don't directly affect Biotricity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biotricity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotricity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotricity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biotricity Accumulated Retained Earnings Deficit vs Trade and Non Trade Receivables Analysis

About Biotricity Balance Sheet Analysis

Biotricity Balance Sheet Chart

Total Assets

Total Current Liabilities

Biotricity fundamental ratios Correlations

Biotricity Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biotricity fundamental ratios Accounts

Pair Trading with Biotricity

Moving together with Biotricity Stock

Moving against Biotricity Stock

Complementary Tools for Biotricity Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.99	Short Long Term Debt Total
Non Current Assets Total	+ 0.99	Short Long Term Debt Total
Short Term Debt	+ 0.99	Total Current Liabilities
Inventory	+ 0.99	Net Debt

Other Stockholder Equity	- 0.97	Retained Earnings
Accounts Payable	- 0.97	Total Stockholder Equity
Net Debt	- 0.97	Total Stockholder Equity
Inventory	- 0.95	Total Stockholder Equity
Total Liab	- 0.94	Retained Earnings
Net Receivables	- 0.94	Retained Earnings